186 related articles for article (PubMed ID: 23492852)
1. Physical model of the immune response of bacteria against bacteriophage through the adaptive CRISPR-Cas immune system.
Han P; Niestemski LR; Barrick JE; Deem MW
Phys Biol; 2013 Apr; 10(2):025004. PubMed ID: 23492852
[TBL] [Abstract][Full Text] [Related]
2. The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.
Levin BR; Moineau S; Bushman M; Barrangou R
PLoS Genet; 2013; 9(3):e1003312. PubMed ID: 23516369
[TBL] [Abstract][Full Text] [Related]
3. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.
Garneau JE; Dupuis MÈ; Villion M; Romero DA; Barrangou R; Boyaval P; Fremaux C; Horvath P; Magadán AH; Moineau S
Nature; 2010 Nov; 468(7320):67-71. PubMed ID: 21048762
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) of Streptococcus thermophilus St-I and its Bacteriophage-Insensitive Mutants (BIM) Derivatives.
Li W; Bian X; Evivie SE; Huo GC
Curr Microbiol; 2016 Sep; 73(3):393-400. PubMed ID: 27378131
[TBL] [Abstract][Full Text] [Related]
5. Genomic impact of CRISPR immunization against bacteriophages.
Barrangou R; Coûté-Monvoisin AC; Stahl B; Chavichvily I; Damange F; Romero DA; Boyaval P; Fremaux C; Horvath P
Biochem Soc Trans; 2013 Dec; 41(6):1383-91. PubMed ID: 24256225
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage.
Common J; Morley D; Westra ER; van Houte S
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180098. PubMed ID: 30905285
[TBL] [Abstract][Full Text] [Related]
7. Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.
Hynes AP; Villion M; Moineau S
Nat Commun; 2014 Jul; 5():4399. PubMed ID: 25056268
[TBL] [Abstract][Full Text] [Related]
8. Costs of CRISPR-Cas-mediated resistance in Streptococcus thermophilus.
Vale PF; Lafforgue G; Gatchitch F; Gardan R; Moineau S; Gandon S
Proc Biol Sci; 2015 Aug; 282(1812):20151270. PubMed ID: 26224708
[TBL] [Abstract][Full Text] [Related]
9. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
[TBL] [Abstract][Full Text] [Related]
10. Strong bias in the bacterial CRISPR elements that confer immunity to phage.
Paez-Espino D; Morovic W; Sun CL; Thomas BC; Ueda K; Stahl B; Barrangou R; Banfield JF
Nat Commun; 2013; 4():1430. PubMed ID: 23385575
[TBL] [Abstract][Full Text] [Related]
11. Variability in the durability of CRISPR-Cas immunity.
Chabas H; Nicot A; Meaden S; Westra ER; Tremblay DM; Pradier L; Lion S; Moineau S; Gandon S
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180097. PubMed ID: 30905283
[TBL] [Abstract][Full Text] [Related]
12. CRISPR immunity drives rapid phage genome evolution in Streptococcus thermophilus.
Paez-Espino D; Sharon I; Morovic W; Stahl B; Thomas BC; Barrangou R; Banfield JF
mBio; 2015 Apr; 6(2):. PubMed ID: 25900652
[TBL] [Abstract][Full Text] [Related]
13. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.
Sapranauskas R; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
Nucleic Acids Res; 2011 Nov; 39(21):9275-82. PubMed ID: 21813460
[TBL] [Abstract][Full Text] [Related]
14. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
Maniv I; Jiang W; Bikard D; Marraffini LA
J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and characterization of chromosomal self-targeting by native CRISPR-Cas systems in Streptococcus thermophilus.
Cañez C; Selle K; Goh YJ; Barrangou R
FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077282
[TBL] [Abstract][Full Text] [Related]
16. Phage mutations in response to CRISPR diversification in a bacterial population.
Sun CL; Barrangou R; Thomas BC; Horvath P; Fremaux C; Banfield JF
Environ Microbiol; 2013 Feb; 15(2):463-70. PubMed ID: 23057534
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-induced distributed immunity in microbial populations.
Childs LM; England WE; Young MJ; Weitz JS; Whitaker RJ
PLoS One; 2014; 9(7):e101710. PubMed ID: 25000306
[TBL] [Abstract][Full Text] [Related]
18. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity.
Seed KD; Lazinski DW; Calderwood SB; Camilli A
Nature; 2013 Feb; 494(7438):489-91. PubMed ID: 23446421
[TBL] [Abstract][Full Text] [Related]
19. Cas9 Cleavage of Viral Genomes Primes the Acquisition of New Immunological Memories.
Nussenzweig PM; McGinn J; Marraffini LA
Cell Host Microbe; 2019 Oct; 26(4):515-526.e6. PubMed ID: 31585845
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
